267875-45-6 Usage
Uses
Used in Pharmaceutical Industry:
3-Pyridinecarboxylic acid, 5,6-diamino-(9CI) is used as a key intermediate in the synthesis of complex compounds for pharmaceutical applications. Its unique structure allows for the development of drugs that target various diseases, such as those related to the central nervous system and the cardiovascular system.
Used in Medicinal Chemistry Research:
3-Pyridinecarboxylic acid, 5,6-diamino-(9CI) is used as a research compound in medicinal chemistry. Its distinctive structure provides a foundation for the exploration of new drug candidates and the investigation of their potential therapeutic effects.
Used in Drug Development:
3-Pyridinecarboxylic acid, 5,6-diamino-(9CI) is used as a building block in the development of new drugs. Its presence in the molecular structure of these compounds can contribute to their pharmacological properties, making it an essential component in the creation of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 267875-45-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,8,7 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 267875-45:
(8*2)+(7*6)+(6*7)+(5*8)+(4*7)+(3*5)+(2*4)+(1*5)=196
196 % 10 = 6
So 267875-45-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O2/c7-4-1-3(6(10)11)2-9-5(4)8/h1-2H,7H2,(H2,8,9)(H,10,11)
267875-45-6Relevant academic research and scientific papers
Thrombin inhibitors
-
, (2008/06/13)
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof, wherein b is NY or O; c is CY2or N; d is CY3or N; e is CY4or N; f is CY5or N; g is CY6or N; Y4, Y5, and Y6are independently hydrogen, C1-4alkyl, or halogen; Y1and Y2are independently hydrogen, C1-4alkyl, C3-7cycloalkyl, halogen, NH2, OH or C1-4alkoxy, and Y3is hydrogen, C1-4alkyl, C3-7cycloalkyl, halogen, —CN, NH2, OH or C1-4alkoxy; A is and W, W1, R1, R3, R4, R5, X and Z are defined in the specification.
Thrombin inhibitors
-
, (2008/06/13)
Compounds of the invention are useful in inhibiting thrombin and treating blood coagulation and cardiovascular disorders and have the following structure: wherein R3 is hydrogen or halogen, and u is N or CH.
